Goldenberg to Lead Clarion's Healthcare / Pharma Arm

New York-based full-service agency Clarion Research has hired Double Helix US founder Jim Goldenberg as Executive Vice President, in charge of its Healthcare and Pharmaceutical division.

Founded in 1995, Clarion offers a range of qual and quant consumer insights solutions for clients in multiple sectors. Goldenberg (pictured) joins with a background in pharmaceutical market research: in 2004, he set up Double Helix's US office, which he led until his recent departure. Before this, he was VP/Account Manager at TNS Healthcare, VP President Business Development at V2 Inc (now GfK Healthcare), and he held senior roles at Migliara Kaplan (acquired by NFO), and IRI.

In his new position, he will work with both existing and new clients, reporting to CEO Diane Traiger, who comments: 'We are thrilled to have a true leader and visionary of Jim's caliber heading our Healthcare and Pharmaceutical business. Jim shares Clarion's passion and heritage for excellence in client service and outstanding analytics. Our combined vast knowledge and network in pharmaceutical research across many therapy areas as well as qualitative and quantitative methodologies will provide tremendous value to our clients'.

Web site: www.clarionresearch.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.